In the week ahead, investors are watching both sides of the Fed’s dual mandate, along with Micron’s report and Eli Lilly’s updates on its obesity pipeline.
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0
